Legend Biotech

Legend Biotech EBIT per Share

The EBIT per Share of Legend Biotech (LEGN) as of Oct 12, 2026 is -0.74 USD. In the previous year, EBIT per Share was -1.66 USD — a change of -55.45% (higher).

EBIT per Share

-0.74USD

YoY

-55.45%

Last updated:

EBIT per Share of Legend Biotech is 2025 -0.74 USD. EBIT per Share of Legend Biotech was 2024 -1.66 USD. It decreases by -55.45% higher compared to the previous year.

The Legend Biotech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
-2.42 USD
Jan 1, 2024
-1.66 USD
Jan 1, 2025
-0.74 USD
Jan 1, 2026 (e)
0.06 USD
Jan 1, 2027 (e)
0.87 USD
Jan 1, 2028 (e)
1.44 USD
Jan 1, 2029 (e)
1.31 USD
Jan 1, 2030 (e)
1.81 USD
The Legend Biotech EBIT per Share history
YEAREBIT per ShareYoY
est1.81USD+38.54%
est1.31USD-9.33%
est1.44USD+66.42%
est0.87USD+1,332.69%
est0.06USD-108.20%
-0.74USD-55.45%
-1.66USD-31.36%
-2.42USD-15.67%
-2.86USD+3.37%
-2.77USD+17.07%
-2.37USD+79.03%
-1.32USD+8,520.17%
-0.02USD-114.69%
0.10USD—
Access this data via the Eulerpool API
Get Free API Key

Legend Biotech Stock analysis

What does Legend Biotech do? Legend Biotech Corp is a leading biopharmaceutical company specializing in the discovery and development of innovative cell therapies for the treatment of serious diseases such as cancer. The company was founded in 2015 as a subsidiary of Genscript Biotech Corp and is headquartered in Somerset, New Jersey, USA. Additionally, the company also operates locations in China and Europe. Legend Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Legend Biotech stock

EBIT per Share of Legend Biotech is -0.74 USD in 2025.

EBIT per Share of Legend Biotech changed from -1.66 USD to -0.74 USD, representing a -55.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Legend Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Legend Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Legend Biotech